[{"id":"d79eae6c-ee5a-4ce6-8ddc-e1255dc5565e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05639153","created_at":"2022-12-06T15:58:04.640Z","updated_at":"2024-07-02T16:35:22.153Z","phase":"Phase 1","brief_title":"A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05639153","lead_sponsor":"Zhejiang Doer Biologics Co., Ltd.","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e DR30303"],"overall_status":"Recruiting","enrollment":" Enrollment 94","initiation":"Initiation: 05/13/2022","start_date":" 05/13/2022","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 04/30/2025","study_completion_date":" 04/30/2025","last_update_posted":"2024-01-25"}]